Literature DB >> 26329323

Post-radiosurgical edema associated with parasagittal and parafalcine meningiomas: a multicenter study.

Jason P Sheehan1, Or Cohen-Inbar2, Rawee Ruangkanchanasetr3, S Bulent Omay4, Judith Hess4, Veronica Chiang4, Christian Iorio-Morin5, Michelle Alonso-Basanta3, David Mathieu5, Inga S Grills6, John Y K Lee3, Cheng-Chia Lee2, L Dade Lunsford7.   

Abstract

Stereotactic radiosurgery (SRS) offers a high degree of tumor control for benign meningiomas. However, radiosurgery can occasionally incite edema or exacerbate pre-existing peri-tumoral edema. The current study investigates the incidence, timing, and extent of edema around parasagittal or parafalcine meningiomas following SRS. A retrospective multicenter review was undertaken through participating centers in the International Gamma Knife Research Foundation (previously the North American Gamma Knife Consortium or NAGKC). All included patients had a parafalcine or parasagittal meningioma and a minimum of 6 months follow up. The median follow up was 19.6 months (6-158 months). Extent of new or worsening edema was quantitatively analyzed using volumetric analysis; edema indices were longitudinally computed following radiosurgery. Analysis was performed to identify prognostic factors for new or worsening edema. A cohort of 212 patients comprised of 51.9 % (n = 110) females, 40.1 % upfront SRS and 59.9 % underwent adjuvant SRS for post-surgical residual tumor. The median tumor volume at SRS was 5.2 ml. Venous sinus compression or invasion was demonstrated in 25 % (n = 53). The median marginal dose was 14 Gy (8-20 Gy). Tumor volume control was determined in 77.4 % (n = 164 out of 212 patients). Tumor edema progressed and then regressed in 33 % (n = 70), was stable or regressed in 52.8 % (n = 112), and progressively worsened in 5.2 % (n = 11). Tumor location, tumor volume, venous sinus invasion, margin, and maximal dose were found to be significantly related to post-SRS edema in multivariate analysis. SRS affords a high degree of tumor control for patients with parasagittal or parafalcine meningiomas. Nevertheless, SRS can lead to worsening peritumoral edema in a subset of patients such as those with larger tumors (>10 cc) and venous sinus invasion/compression. Long-term follow up is required to detect and appropriately manage post-SRS edema.

Entities:  

Keywords:  Edema; Gamma Knife; Meningioma; Radiosurgery

Mesh:

Year:  2015        PMID: 26329323     DOI: 10.1007/s11060-015-1911-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

Review 1.  Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.

Authors:  Damoun Nassehi
Journal:  Dan Med J       Date:  2013-04       Impact factor: 1.240

2.  The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas.

Authors:  Michael E Sughrue; Ari J Kane; Gopal Shangari; Martin J Rutkowski; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2010-04-09       Impact factor: 5.115

3.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Authors:  Victor A Levin; Luc Bidaut; Ping Hou; Ashok J Kumar; Jeffrey S Wefel; B Nebiyou Bekele; Jai Grewal; Sujit Prabhu; Monica Loghin; Mark R Gilbert; Edward F Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-01       Impact factor: 7.038

4.  Significance of tumor volume related to peritumoral edema in intracranial meningioma treated with extreme hypofractionated stereotactic radiation therapy in three to five fractions.

Authors:  Masahiro Morimoto; Yasuo Yoshioka; Hiroya Shiomi; Fumiaki Isohashi; Koji Konishi; Tadayuki Kotsuma; Shoichi Fukuda; Naoki Kagawa; Manabu Kinoshita; Naoya Hashimoto; Toshiki Yoshimine; Masahiko Koizumi
Journal:  Jpn J Clin Oncol       Date:  2011-03-16       Impact factor: 3.019

5.  Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema.

Authors:  Tadashi Osawa; Masahiko Tosaka; Masaya Nagaishi; Yuhei Yoshimoto
Journal:  J Neurooncol       Date:  2012-10-27       Impact factor: 4.130

6.  Prediction of intracranial edema after radiosurgery of meningiomas.

Authors:  Josef Novotný; Aurelia Kollová; Roman Liscák
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

7.  Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery.

Authors:  Christopher P Deibert; Manmeet S Ahluwalia; Jason P Sheehan; Michael J Link; Toshinori Hasegawa; Shoji Yomo; Wu Han Feng; Pan Li; John C Flickinger; L Dade Lunsford; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2013-08-09       Impact factor: 4.130

8.  Radiosurgery for parasagittal and parafalcine meningiomas.

Authors:  Dale Ding; Zhiyuan Xu; Ian T McNeill; Chun-Po Yen; Jason P Sheehan
Journal:  J Neurosurg       Date:  2013-08-09       Impact factor: 5.115

9.  Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development.

Authors:  Peter Kan; James K Liu; Merideth M Wendland; Dennis Shrieve; Randy L Jensen
Journal:  J Neurooncol       Date:  2007-01-24       Impact factor: 4.506

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  9 in total

1.  The radiosurgery fractionation quandary: single fraction or hypofractionation?

Authors:  John P Kirkpatrick; Scott G Soltys; Simon S Lo; Kathryn Beal; Dennis C Shrieve; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 2.  An overview of meningiomas.

Authors:  Robin A Buerki; Craig M Horbinski; Timothy Kruser; Peleg M Horowitz; Charles David James; Rimas V Lukas
Journal:  Future Oncol       Date:  2018-08-07       Impact factor: 3.404

Review 3.  Hypofractionated stereotactic radiotherapy for intracranial meningioma: a systematic review.

Authors:  Eric K Nguyen; Timothy K Nguyen; Gabe Boldt; Alexander V Louie; Glenn S Bauman
Journal:  Neurooncol Pract       Date:  2018-12-20

4.  Linear Accelerator-Based Radiosurgery of Grade I Intracranial Meningiomas.

Authors:  Sara Alatriste-Martínez; Sergio Moreno-Jiménez; Guillermo A Gutiérrez-Aceves; José de Jesús Suárez-Campos; Olivia Amanda García-Garduño; Alejandro Rosas-Cabral; Miguel Ángel Celis-López
Journal:  World Neurosurg X       Date:  2019-03-07

Review 5.  Ten-year follow-up after Gamma Knife radiosurgery of meningioma and review of the literature.

Authors:  Bodo E Lippitz; Jiri Bartek; Tiit Mathiesen; Petter Förander
Journal:  Acta Neurochir (Wien)       Date:  2020-06-26       Impact factor: 2.216

6.  Meningioma Treated With Hypofractionated Stereotactic Radiotherapy Using CyberKnife®: First in the United Arab Emirates.

Authors:  Nandan M Shanbhag; Christos Antypas; Abdul K Msaddi; Sinead Catherine Murphy; Teekendra T Singh
Journal:  Cureus       Date:  2022-02-01

7.  Pseudoprogression and peritumoral edema due to intratumoral necrosis after Gamma knife radiosurgery for meningioma.

Authors:  In-Ho Jung; Kyung Won Chang; So Hee Park; Hyun Ho Jung; Jong Hee Chang; Jin Woo Chang; Won Seok Chang
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

8.  MR Venography in Gamma Knife Radiosurgery for Parasagittal Meningiomas: A Technical Note with the Rationale of Venous Protection and a Review of Literature.

Authors:  Sushanta Kumar Sahoo; Chirag Kamal Ahuja; Sivashanmugam Dhandapani; Renu Madan; Parsee Tomar; Sushil Kumar; Manjeet Kaur
Journal:  Asian J Neurosurg       Date:  2021-05-28

9.  Post-Treatment Edema after Meningioma Radiosurgery is a Predictable Complication.

Authors:  Alfredo Conti; Antonio Pontoriero; Francesca Siddi; Giuseppe Iatì; Salvatore Cardali; Filippo F Angileri; Francesca Granata; Stefano Pergolizzi; Antonino Germanò; Francesco Tomasello
Journal:  Cureus       Date:  2016-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.